Radiotherapy/Radiation / GutMicro Cancer Research Results
Rad, Radiotherapy/Radiation: Click to Expand ⟱
| Features: |
Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes.
Radiosensitizer
Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer.
|
GutMicro, Gut Microbiota: Click to Expand ⟱
| Source: |
| Type: |
Gut microbiome may affect responses to numerous forms of cancer therapy.
The gut microbiota plays a multifaceted role in cancer biology, influencing tumor development, progression, and patient prognosis. Dysbiosis and specific microbial populations have been linked to various cancers, with implications for patient outcomes. While the relationship between gut microbiota and cancer prognosis is an active area of research, it holds promise for the development of microbiome-based biomarkers and therapeutic strategies in oncology.
|
Scientific Papers found: Click to Expand⟱
*radioP↑, GutMicro↑, *P53↓, *Apoptosis↑, *DR4↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Clinical Biomarkers ⓘ
GutMicro↑, 1,
Total Targets: 1
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
Apoptosis↑, 1, DR4↓, 1,
DNA Damage & Repair ⓘ
P53↓, 1,
Functional Outcomes ⓘ
radioP↑, 1,
Total Targets: 4
Scientific Paper Hit Count for: GutMicro, Gut Microbiota
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:201 Target#:350 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page